Ardelyx Future Growth
Future criteria checks 6/6
Ardelyx is forecast to grow earnings and revenue by 55.3% and 21.1% per annum respectively. EPS is expected to grow by 54.9% per annum. Return on equity is forecast to be 52.7% in 3 years.
Key information
55.3%
Earnings growth rate
54.9%
EPS growth rate
| Biotechs earnings growth | 29.6% |
| Revenue growth rate | 21.1% |
| Future return on equity | 52.7% |
| Analyst coverage | Good |
| Last updated | 03 Feb 2025 |
Recent future growth updates
Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Nov 03
Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Aug 04Ardelyx, Inc. (NASDAQ:ARDX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
May 04Recent updates
Ardelyx: A Small Bet Its Latest Setback Will Be Temporary
Dec 20Ardelyx Lost The Lawsuit, But The Kidney PATIENT Act Will Save It
Nov 24Ardelyx's Medicare Setback Casts Doubt On Long-Term Viability
Nov 14Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Nov 03Ardelyx, Inc.'s (NASDAQ:ARDX) Shares Lagging The Industry But So Is The Business
Oct 24Is Ardelyx (NASDAQ:ARDX) Weighed On By Its Debt Load?
Aug 25Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts
Aug 07Ardelyx Faces Rising Challenges Despite Revenue Growth
Aug 05Earnings Beat: Ardelyx, Inc. (NASDAQ:ARDX) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Aug 04Ardelyx: Increased Focus On Ibsrela Due To Xphozah's Uncertain Outlook
Jul 13Why Investors Shouldn't Be Surprised By Ardelyx, Inc.'s (NASDAQ:ARDX) 25% Share Price Plunge
Jul 05Ardelyx: Strong Execution, Fairly Valued
May 10Ardelyx, Inc. (NASDAQ:ARDX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
May 04Ardelyx Stock: A Crowded Market Curbs The Enthusiasm (Rating Downgrade)
May 03Ardelyx, Inc.'s (NASDAQ:ARDX) Popularity With Investors Is Under Threat From Overpricing
Apr 17Ardelyx Shrugs Off 'Mixed' Q4 Earnings
Mar 13Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
Feb 24Ardelyx Q4 Preview: Recent Bull Run May Pause While Market Digests 2024 Guidance
Feb 20Ardelyx's XPHOZAH Still An Afterthought To The Pros
Jan 31Ardelyx: FDA Approval For Xphozah Grants Further Sales Enhancement
Jan 10Ardelyx, Inc.'s (NASDAQ:ARDX) Business Is Yet to Catch Up With Its Share Price
Jan 04Despite Lacking Profits Ardelyx (NASDAQ:ARDX) Seems To Be On Top Of Its Debt
Dec 14Party Time: Brokers Just Made Major Increases To Their Ardelyx, Inc. (NASDAQ:ARDX) Earnings Forecasts
Aug 03Rock star Growth Puts Ardelyx (NASDAQ:ARDX) In A Position To Use Debt
Jul 31Pinning Down Ardelyx, Inc.'s (NASDAQ:ARDX) P/S Is Difficult Right Now
Apr 17Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Mar 30Is Ardelyx (NASDAQ:ARDX) Using Debt Sensibly?
Dec 14Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2027 | 613 | 208 | 295 | 303 | 6 |
| 12/31/2026 | 486 | 83 | 181 | 147 | 8 |
| 12/31/2025 | 371 | -46 | 35 | 36 | 8 |
| 12/31/2024 | 329 | -39 | N/A | -22 | 8 |
| 9/30/2024 | 252 | -73 | -64 | -63 | N/A |
| 6/30/2024 | 210 | -65 | -86 | -85 | N/A |
| 3/31/2024 | 159 | -66 | -81 | -81 | N/A |
| 12/31/2023 | 124 | -66 | -90 | -90 | N/A |
| 9/30/2023 | 134 | -27 | -67 | -67 | N/A |
| 6/30/2023 | 83 | -56 | -71 | -71 | N/A |
| 3/31/2023 | 63 | -66 | -87 | -87 | N/A |
| 12/31/2022 | 52 | -67 | -70 | -70 | N/A |
| 9/30/2022 | 9 | -114 | -124 | -124 | N/A |
| 6/30/2022 | 5 | -135 | -133 | -133 | N/A |
| 3/31/2022 | 4 | -153 | -137 | -136 | N/A |
| 12/31/2021 | 10 | -158 | -154 | -153 | N/A |
| 9/30/2021 | 11 | -151 | -133 | -131 | N/A |
| 6/30/2021 | 12 | -125 | -118 | -116 | N/A |
| 3/31/2021 | 13 | -105 | -102 | -101 | N/A |
| 12/31/2020 | 8 | -94 | -82 | -81 | N/A |
| 9/30/2020 | 8 | -85 | -75 | -75 | N/A |
| 6/30/2020 | 8 | -91 | -76 | -76 | N/A |
| 3/31/2020 | 6 | -91 | -85 | -85 | N/A |
| 12/31/2019 | 5 | -95 | -77 | -76 | N/A |
| 9/30/2019 | 3 | -103 | -84 | -84 | N/A |
| 6/30/2019 | 0 | -104 | -91 | -90 | N/A |
| 3/31/2019 | 0 | -100 | -81 | -80 | N/A |
| 12/31/2018 | 3 | -91 | -71 | -70 | N/A |
| 9/30/2018 | 45 | -53 | -47 | -47 | N/A |
| 6/30/2018 | 44 | -50 | N/A | -39 | N/A |
| 3/31/2018 | 44 | -53 | N/A | -45 | N/A |
| 12/31/2017 | 42 | -64 | N/A | -65 | N/A |
| 9/30/2017 | N/A | -106 | N/A | -97 | N/A |
| 6/30/2017 | N/A | -114 | N/A | -102 | N/A |
| 3/31/2017 | N/A | -117 | N/A | -103 | N/A |
| 12/31/2016 | N/A | -112 | N/A | -93 | N/A |
| 9/30/2016 | N/A | -98 | N/A | -87 | N/A |
| 6/30/2016 | N/A | -87 | N/A | -75 | N/A |
| 3/31/2016 | 18 | -50 | N/A | -80 | N/A |
| 12/31/2015 | 24 | -30 | N/A | -72 | N/A |
| 9/30/2015 | 30 | -16 | N/A | -54 | N/A |
| 6/30/2015 | 38 | 2 | N/A | -48 | N/A |
| 3/31/2015 | 29 | -6 | N/A | 6 | N/A |
| 12/31/2014 | 32 | -3 | N/A | 13 | N/A |
| 9/30/2014 | 34 | -4 | N/A | 28 | N/A |
| 6/30/2014 | 33 | -5 | N/A | 34 | N/A |
| 3/31/2014 | 31 | -7 | N/A | 5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ARDX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: ARDX is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ARDX is expected to become profitable in the next 3 years.
Revenue vs Market: ARDX's revenue (21.1% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: ARDX's revenue (21.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ARDX's Return on Equity is forecast to be very high in 3 years time (52.7%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 01:28 |
| End of Day Share Price | 2025/02/07 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ardelyx, Inc. is covered by 17 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Timothy Chiang | BTIG |
| Mara Goldstein | Cantor Fitzgerald & Co. |
| Louise Chen | Cantor Fitzgerald & Co. |